Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone propionate/salmeterol versus fluticasone propionate for asthma safety and efficacy
NL-OMON37915Phase 4Withdrawn
- Sponsor
- GSK
- Start
- Feb 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in asthma comparing Fluticasone propionate monotherapy with Fluticasone propionate + salmeterol combination therapy (2 arms). Primary endpoint: Composite serious asthma outcomes. Planned start Feb 2012; status: withdrawn.
02
Drugs
fluticasone propionatesalmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on NL-OMON37915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37915.